IGCN: Integrative Graph Convolution Networks for patient level insights and biomarker discovery in multi-omics integration
This work addresses the need for interpretable tools in precision medicine for cancer researchers, though it appears incremental as it builds on existing graph convolutional networks.
The authors tackled the problem of lacking interpretability in multi-omics data integration for cancer research by introducing IGCN, a method that provides patient-level insights and biomarker discovery, achieving superior performance compared to state-of-the-art approaches in classification tasks.
Developing computational tools for integrative analysis across multiple types of omics data has been of immense importance in cancer molecular biology and precision medicine research. While recent advancements have yielded integrative prediction solutions for multi-omics data, these methods lack a comprehensive and cohesive understanding of the rationale behind their specific predictions. To shed light on personalized medicine and unravel previously unknown characteristics within integrative analysis of multi-omics data, we introduce a novel integrative neural network approach for cancer molecular subtype and biomedical classification applications, named Integrative Graph Convolutional Networks (IGCN). IGCN can identify which types of omics receive more emphasis for each patient to predict a certain class. Additionally, IGCN has the capability to pinpoint significant biomarkers from a range of omics data types. To demonstrate the superiority of IGCN, we compare its performance with other state-of-the-art approaches across different cancer subtype and biomedical classification tasks.